By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytoDyn 

1111 Main Street
Suite 660
Vancouver  Washington  98660  U.S.A.
Phone: 360-980-8524 Fax: 360-980-8549


SEARCH JOBS


Industry
Biotechnology






Company News
CytoDyn (CYDY) Announces $10.0 Million Registered Direct Offering 9/12/2016 7:55:21 AM
CytoDyn (CYDY) To Present At Rodman & Renshaw Global Investment Conference On September 12 9/8/2016 7:55:36 AM
CytoDyn (CYDY) Release: Patients Approach Two Years Of Complete HIV Viral Load Suppression In Phase IIb PRO 140 Monotherapy Extension Study 8/23/2016 7:56:21 AM
CytoDyn (CYDY) Announces Investment Community Conference Call For August 19, 2016 8/18/2016 7:41:56 AM
First Patient Enrolled Under Newly Modified Protocol In CytoDyn (CYDY)’s Phase III PRO 140 Combination Study In HIV 7/26/2016 7:44:13 AM
CytoDyn (CYDY) Submits Orphan Drug Application To FDA For Pretreatment With PRO 140 Of Treatment-Naïve HIV Patients 7/21/2016 12:53:29 PM
CytoDyn (CYDY) Submits Protocol for Phase IIb Trial for Treatment Naïve HIV Patients 7/19/2016 8:07:28 AM
CytoDyn (CYDY) Announces Investment Community Conference Call For July 13, 2016 7/11/2016 8:19:33 AM
ASM Microbe 2016 Presentation of Clinical Results From CytoDyn (CYDY)’s Phase IIb Monotherapy Extension Study Now Available 6/22/2016 7:43:22 AM
CytoDyn (CYDY)n’s PRO 140 Phase IIb HIV Monotherapy Trial Findings To Be Presented At ASM Microbe 2016 Conference On June 20 6/17/2016 8:08:47 AM
12345678910...
//-->